Example
Risk and the Physicians’ Health Study
Researchers in the Physicians’ Health Study (1989) designed a randomized clinical trial to determine whether aspirin reduces the risk of heart attack. Researchers randomly assigned a large sample of healthy male physicians (22,071) to one of two groups. One group took a low dose of aspirin (325 mg every other day). The other group took a placebo. This was a double-blind experiment. Here are the final results.
| Heart Attack | No Heart Attack | Row Totals |
Aspirin | 139 | 10,898 | 11,037 |
Placebo | 239 | 10,795 | 11,034 |
Column Totals | 378 | 21,693 | 22,071 |
Note that the categorical variables in this case are
- Explanatory variable: Treatment (aspirin or placebo)
- Response variable: Medical outcome (heart attack or no heart attack)
Question:
Does aspirin lower the risk of having a heart attack?
To answer this question, we compare two conditional probabilities:
- The probability of a heart attack given that aspirin was taken every other day.
- The probability of a heart attack given that a placebo was taken every other day.
From the table we have
- P(heart attack | aspirin) = 139 / 11,037 = 0.013
- P(heart attack | placebo) = 239 / 11,034 = 0.022
The result shows that taking aspirin reduced the risk from 0.022 to 0.013.
We often compare two risks by calculating the percentage change. We calculate the difference (how much the risk changed) and divide by the risk for the placebo group.
Here is the calculation:
Therefore, we conclude that taking aspirin results in a 41% reduction in risk.
As reported in the New England Journal of Medicine, “This trial of aspirin for the primary prevention of cardiovascular disease demonstrates a conclusive reduction in the risk of myocardial infarction (heart attack).” (Source: “Final Report on the Aspirin Component of the Ongoing Physicians’ Health Study,” New England Journal of Medicine 321(3):129–35, 1989.)
In the preceding example, we compared the difference in risk (how much the risk changed) to the risk for the placebo (nontreatment) group:
In general, we are interested in determining how much a new treatment reduces the risk compared to a reference risk. The reference may be nontreatment (e.g., use of a placebo), or it could be an existing treatment that we hope to improve on. So we have:
The following table is used for the next Try It activity.
Let’s summarize our work with probability. We defined three kinds of probabilities related to a two-way table.
When we calculate the probability of a negative outcome like a heart attack, we often refer to the probability as a risk. We compare risk by calculating the percentage change: